Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. on September 2, 2025. The report addresses a regulatory matter concerning the company's continued listing on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on a compliance notification rather than financial performance data.
Material Changes
The primary event reported is the resolution of a listing compliance issue. Nasdaq determined that Celularity Inc. complies with Listing Rule 5250(c)(1) based on the company's Form 10-Q filings for the periods ended March 31, 2025, and June 30, 2025. Consequently, the matter regarding the company's listing status is now closed.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of new risks or contingencies. The document confirms the closure of a specific regulatory matter without introducing unusual items.
Key Facts for Investor Verification
- Celularity Inc. has received formal confirmation from Nasdaq that it is in compliance with Listing Rule 5250(c)(1).
- The compliance determination was based on the company's Form 10-Q filings for the quarters ended March 31, 2025, and June 30, 2025.
- The regulatory matter regarding the company's listing status is officially closed as of September 2, 2025.
- The company's Class A Common Stock (CELU) and Warrants (CELUW) remain registered on The Nasdaq Stock Market LLC.